Product Information
PROCTOZONE-HC 2.5% CREAM is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2350 per GM under NDC 64980032430. Its NADAC has been published 566 times since Nov 4, 2015.
FDA first approved this application on Aug 20, 2010. Its Orange Book therapeutic-equivalence code is AT.
Strength
25 mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
64980032430
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONEApproval Type
Generic (ANDA)
FDA Application
ANDA040879FDA Approved
8/20/2010
TE Code
AT
On Market Since
8/3/2015
Pharmacological Classes
Price Statistics
The NADAC for PROCTOZONE-HC 2.5% CREAM has been published 566 times since Nov 4, 2015, and over the history we have for it it has declined 88.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2350 per GM |
|---|---|
| All-time high | $2.0449 (Dec 16, 2015) |
| All-time low | $0.2040 (Nov 20, 2024) |
| 52-week high | $0.2641 |
| 52-week low | $0.2345 |
| Median price | $0.3755 |
| Average price | $0.5817 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 566 |
| Tracking since | Nov 4, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocortisone 2.5% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocortisone 2.5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCTOZONE-HC 2.5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for PROCTOZONE-HC 2.5% CREAM, manufactured by Rising Pharma Holdings Inc., is $0.2350 per GM (NDC 64980032430), effective Sep 30, 2026.
How has the price of PROCTOZONE-HC 2.5% CREAM changed over time?
Over the history we have for it, the NADAC for PROCTOZONE-HC 2.5% CREAM has declined 88.3%. It has been tracked across 566 weekly CMS publications since Nov 4, 2015.
What are the highest and lowest recorded NADAC prices for PROCTOZONE-HC 2.5% CREAM?
Since Nov 4, 2015, the NADAC for PROCTOZONE-HC 2.5% CREAM has ranged from a low of $0.2040 (Nov 20, 2024) to a high of $2.0449 (Dec 16, 2015), with a median of $0.3755 per GM.
Are there cheaper alternatives to PROCTOZONE-HC 2.5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of PROCTOZONE-HC 2.5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCTOZONE-HC 2.5% CREAM?
PROCTOZONE-HC 2.5% CREAM (NDC 64980032430) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.